1. Home
  2. SCLX vs GROV Comparison

SCLX vs GROV Comparison

Compare SCLX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$5.86

Market Cap

55.1M

Sector

Health Care

ML Signal

N/A

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

N/A

Current Price

$0.98

Market Cap

52.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
GROV
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
55.1M
52.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SCLX
GROV
Price
$5.86
$0.98
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$1.60
AVG Volume (30 Days)
59.5K
24.7K
Earning Date
04-10-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.26
EPS
N/A
N/A
Revenue
$30,253,000.00
$173,716,000.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
$6.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$1.01
52 Week High
$34.27
$1.59

Technical Indicators

Market Signals
Indicator
SCLX
GROV
Relative Strength Index (RSI) 33.68 36.46
Support Level $5.48 N/A
Resistance Level $7.77 $1.17
Average True Range (ATR) 0.42 0.06
MACD -0.08 -0.00
Stochastic Oscillator 13.24 34.25

Price Performance

Historical Comparison
SCLX
GROV

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.

Share on Social Networks: